Step 1

It starts with a trip
to your doctor

to see if EVO ICL (EVO) is right for you.

Step 2


Your eyes are examined and precisely measured by your doctor to ensure each EVO lens is suited to your eye's personal characteristics.

Step 3

the lenses

The doctor uses EVO lens software to assist in calculating, selecting, and ordering the proper customized lens.

Step 4

of Collamer®

a soft, flexible and biocompatible material, unique to STAAR, is selected for you.

Step 5

the lens

Next, it’s made into the shape of the EVO lens.

Step 6

milling arm

A precision milling arm is used to cut each lens to its exact specifications.

Step 7

and polished

Then it is handcrafted and polished, tumbled and hydrated until it is exactly right.

Step 8

Rigorous testing
and inspection

Finally, each EVO lens undergoes rigorous testing and inspection to meet our premium standards.

Step 9

to the doctor

The lenses are delivered to the doctor who has ordered them.

Step 10

of the lens

The personalized EVO lenses are implanted by your doctor.

Step 11


An evolution
in visual freedom

ICLs have been around for over 20 years and over 2 million lenses have been distributed worldwide. 99.4% of patients surveyed said they would have the procedure again.¹

Jj testimonial page mobile

Joe Jonas

Joe Jonas dreamed of a day where he could live life uninhibited by his nearsightedness. Joe had the EVO procedure to correct his distance vision. See his story on how he broke free from the hassles of contacts and glasses.

Prêt à découvrir la liberté visuelle grâce à EVO ICL? Trouver un médecin aujourd’hui

Informations importantes sur la sécurité

The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.



1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council